Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer-Reference-Cited by-同舟云学术

Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer

Published:2019-10-31 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Coleridge Sarah L¹,Bryant Andrew²,Lyons Thomas J³,Goodall Richard J⁴,Kehoe Sean⁵,Morrison Jo⁶

Affiliation:

1. Taunton and Somerset NHS Foundation Trust; Obstetrics and Gynaecology; Musgrove Park Hospital Taunton UK TA1 5DA

2. Newcastle University; Institute of Health & Society; Medical School New Build Richardson Road Newcastle upon Tyne UK NE2 4AX

3. University of Bristol; School of Medical Sciences; 38 Kings Parade Avenue Bristol UK BS8 2RB

4. Imperial College London; Department of Surgery and Cancer; Kensington London UK SW7 2AZ

5. University of Birmingham; Institute of Cancer and Genomics; Birmingham UK B15 2TT

6. Musgrove Park Hospital; Department of Gynaecological Oncology; Taunton and Somerset NHS Foundation Trust Taunton Somerset UK TA1 5DA

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005343.pub4/epdf/full

Reference201 articles.

1. An open prospective randomized trial comparing primary complete cytoreduction surgery to debulking surgery after chemotherapy in advanced stage (FIGO's IIIC) ovarian carcinoma;Chekman;Conference Publication,2015

2. Fagotti A Ferrandina G Vizzielli G Fanfani F Gallotta V Chiantera V Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome European Journal of Cancer 2016 22 33

3. Fagotti A Vizzielli G Ferrandina G Fanfani F Gallotta V Chiantera V Survival analyses from a randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer with high tumor load (SCORPION trial) Journal of Clinical Oncology 2018 5516

4. Kehoe S Chemotherapy or upfront surgery for newly diagnosed advanced ovarian cancer: Results from the MRC chorus trial International Journal of Gynecological Cancer 2013 17

5. Kehoe S Hook J Nankivell M Chemotherapy or upfront surgery for newly diagnosed advanced ovarian cancer: results from the MRC CHORUS trial Journal of Clinical Oncology 2013 Abstract 5500

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of the efficacy and safety of anlotinib for the treatment of recurrent epithelial ovarian cancer;Discover Oncology;2024-08-29

2. The microbiome and ovarian cancer: insights, implications, and therapeutic opportunities;Journal of Cancer Metastasis and Treatment;2023-11-23

3. MDT practice determines treatment pathway for patients with advanced ovarian cancer: A multi-centre observational study;European Journal of Surgical Oncology;2023-08

4. Management of patients with advanced epithelial ovarian cancer: a European survey;Archives of Gynecology and Obstetrics;2023-02-03

5. A Rare Case of Primary Peritoneal Carcinoma With Large Bowel Metastasis;Cureus;2023-01-24